Regeneron Pharmaceuticals, Inc. announced that newly updated National Institutes of Health (NIH) Covid-19 Treatment Guidelines strongly recommend that REGEN-COV (casirivimab with imdevimab) be used in ...
The FDA has authorized a new version of Regeneron’s COVID-19 drug that can be given by injection, which should make it easier to give to patients. Regeneron said June 4 the FDA is now allowing the ...
We're maintaining our $570 fair value estimate for Regeneron after the firm reported strong third-quarter results, driven by what we see as a combination of near-term demand for COVID-19 antibody ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback